Maria Bourlon: iPARPs in prostate cancer
Maria Bourlon shared a post by Therapeutic Advances in Medical Oncology, on X, adding:
”Our article of iPARPs in prostate cancer a top-read in Therapeutic Advances in Medical Oncology.
A Mexico-Spain collaboration.”
Quoting Therapeutic Advances in Medical Oncology’s post:
”Top-read in TAM: The development of PARP inhibitors in advanced prostate cancer. Check out the comprehensive review on therapeutic strategies and synergies.
Authors: Maria Bourlon, Paola Valdez, Elena Castro.”
Source: Maria Bourlon/X and Therapeutic Advances in Medical Oncology/X
Maria Bourlon is an Associate Professor and Head of the Urologic Oncology Clinic at Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico. She is the Director of the Genitourinary Cancers Program at Universidad Nacional Autónoma de México. Dr. Bourlon is the chair-elect of the American Society of Clinical Oncology IDEA Steering Group and in 2023 received the prestigious ASCO CCF International Women Who Conquer Cancer (WWCC) Mentorship Award. She is on the Editorial Board of OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023